v. ****-**-** Page * of *

MARY C. MURPHY

PO Box 782, East Lyme, CT 06333

+1-617-***-**** actgag@r.postjobfree.com

SUMMARY: Accomplished, well-rounded and results-driven scientific professional with extensive scientific and project management experience. Twenty years experience in the pharmaceutical industry, with a solid understanding of the drug development process. Demonstrated ability to create sound, scientific and practical solutions in laboratory and other settings. Key strengths include external vendor/collaborator management, oversight and coordination; team building, consensus development, project management, and organizational aptitude. Delivers high quality results, meeting or exceeding stakeholder expectations in both laboratory and team settings Able to rapidly assimilate new requirements, technologies, and processes. Successfully managed multiple projects with competing priorities within established timelines. Demonstrated expertise in understanding and translating customer and stakeholder requirements into actionable plans; successfully executing against agreed strategy. Effectively works with external partners in internal and external collaborations to deliver against strict timelines. GOAL: Securing a role in Clinical Research, Operations or Project Management to leverage my expertise and experience. PROFESSIONAL EXPERIENCE

PHARMACEUTICAL SCIENTIST, PFIZER INC GLOBAL RESEARCH AND DEVELOPMENT, Groton, CT

In these roles, I have demonstrated the ability to: o Effectively scope and lead project team meetings, update team on plans and timelines, recap outcomes, ensure alignment across lines and functions, highlight critical path activities and follow up on agreed actions until resolution achieved

o Challenge team members assumptions and plans to ensure appropriate strategic and operational implementation

o Identify and ensure key partner lines are included in appropriate discussions by issuing timely communications and maintaining project databases

o Quickly adopt, and where appropriate, enhance or develop novel approaches in the identification and development of pharmaceutical products

o Rapidly integrate new requirements and changes to programs with no downtime or interruption o Bridge internal and external partnerships to drive effective program delivery Primary Pharmacology Group (PPG), 2009-2013

Led internal and external assay transfer to external partners (ex-US); managed technical relationships with external-vendor teams for reagent logistics, assay development, data analysis, and intervention activities.

Scientific representative for external collaborations on multiple projects.

Ensured timely delivery of data for a number of time critical projects.

Served as technical point of contact for internal Research Unit partners and external assay partners; led QC review of all data from external partners.

Collaborated across Research Lines to ensure project activities advanced as agreed.

Implemented suite of functional and binding studies for Neuroscience projects.

Execute plate based pharmacology studies for several projects; screening technologies include Luminescence, Fluorescence, Absorbance, Scintillaton Proximity Assay, and ELISA.

Co-led assay development, optimization, and transfer of critical assays to external vendors in India and China.

Executed series of panel assays to support the selectivity requests from all Research units (Neurosciences; Cardiovascular; Metabolic Diseases).

Developed alternative coupled-assay for project studies, which led to advancement of multiple compounds into development.

Supported key intellectual property (IP) filings and publications for multiple projects. v. 2015-02-25 Page 2 of 2

MARY C. MURPHY actgag@r.postjobfree.com

PROFESSIONAL EXPERIENCE

PHARMACEUTICAL SCIENTIST, PFIZER INC, GLOBAL RESEARCH AND DEVELOPMENT (continued) Cardiovascular, Metabolic and Endocrine Disease (CVMED) Biology, 2007-2009

Led scientific operations with external partner located in India; traveled to India to optimize and finalize logistics associated with outsourcing efforts.

Developed primary and secondary assays and successfully accomplished technical transfer to outsourcing partner, including all materials and reagents.

Researched and ensured activities met all requirements and regulations in host country.

Worked with partner to identify methods to transfer data, compounds, etc. to ensure successful implementation.

Attended and led weekly conferences between partners as well as semi-monthly management conferences between partner and senior corporate leadership.

Analyzed data output from partner efforts; provided feedback and guidance to partner to ensure appropriate delivery results.

Lead Generation Group (LGG), and New Leads Biology, 1999-2007

Selected to lead Neurosciences assay efforts on a high-priority project; identified series critical in enabling program to transition to early decision-making development stage; trained neurosciences project team on required techniques.

Presented at group and department meetings and provided updates to management.

Rapidly prosecuted and successfully identified multiple chemical series, within established/agreed timelines

Planned and executed strategy to prosecute HTS quickly and efficiently using automated systems, while running high-throughput screenings (HTS) for cardiovascular therapeutics

Recognized as first associate scientist to screen 500,000 compounds in one day.

Managed multiple programs across development sites, including established protocols for cancer project and control data to evaluate outcomes; ensured quality control of results.

Transitioned a number of assays to Pfizer overseas sites; supported project on ad-hoc basis by providing assay development reports and updates, reagents/materials, and detailed protocol transfers.

Redeveloped assay to improve method for high-throughput screening.

Contributed to key technology work streams, investigating new equipment and technologies as well as developing SOPs for existing equipment.

Piloted use of Immobilized Metal ion Affinity-based fluorescence Polarization (IMAP) and Luminescence technologies for HTS screening, replacing radioactive assays; approach subsequently widely adopted at Pfizer.

Demonstrated expertise on a wide variety of equipment, including Tecan, Tomtec Quadra, Platemate 2x2, LJL Analyst, GT Analyst, Multidrop, Apricot pipettor, Titertek Multiskan Ascent, and Trilux Microbeta.

Assisted with Accelerated Intelligent Drug Discovery (AIDD) initiative, running a series of panel screens; this program was a collaboration with external partner

Department of Natural Products, 1992-1999

Provided chemistry and microbiology support, processing plant extracts to prepare for HTS screening.

Performed HPLC analysis and new method development for microbial extracts, while supporting microbiology media studies: prep HPLC, chromatography, extractions, and crystallization with both organic and water soluble compounds.

Designed solid phase extraction studies to devise method for processing microbial extracts. EDUCATION

UNIVERSITY OF CONNECTICUT, Storrs, CT

Bachelor of Science, Molecular and Cell Biology

Contact this candidate